211 related articles for article (PubMed ID: 26677889)
1. Should routine laboratories stop doing screening serum protein electrophoresis and replace it with screening immune-fixation electrophoresis? No quick fixes: Counterpoint.
Smith JD; Raines G; Schneider HG
Clin Chem Lab Med; 2016 Jun; 54(6):967-71. PubMed ID: 26677889
[TBL] [Abstract][Full Text] [Related]
2. Screening immunofixation should replace protein electrophoresis as the initial investigation of monoclonal gammopathy: Point.
Pretorius CJ
Clin Chem Lab Med; 2016 Jun; 54(6):963-6. PubMed ID: 26574893
[TBL] [Abstract][Full Text] [Related]
3. A comparison between high resolution serum protein electrophoresis and screening immunofixation for the detection of monoclonal gammopathies in serum.
Smith J; Raines G; Schneider HG
Clin Chem Lab Med; 2018 Jan; 56(2):256-263. PubMed ID: 28787269
[TBL] [Abstract][Full Text] [Related]
4. Optimization of utilization of serum protein analysis: role of the electronic medical record in promoting consultation by pathology.
Zia HM; Singh G
Am J Clin Pathol; 2013 Jun; 139(6):793-7. PubMed ID: 23690123
[TBL] [Abstract][Full Text] [Related]
5. Can serum free light chains replace urine electrophoresis in the detection of monoclonal gammopathies?
Beetham R; Wassell J; Wallage MJ; Whiteway AJ; James JA
Ann Clin Biochem; 2007 Nov; 44(Pt 6):516-22. PubMed ID: 17961305
[TBL] [Abstract][Full Text] [Related]
6. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays.
Katzmann JA; Dispenzieri A; Kyle RA; Snyder MR; Plevak MF; Larson DR; Abraham RS; Lust JA; Melton LJ; Rajkumar SV
Mayo Clin Proc; 2006 Dec; 81(12):1575-8. PubMed ID: 17165636
[TBL] [Abstract][Full Text] [Related]
7. Comparison of serum immunofixation electrophoresis and free light chain assays in the detection of monoclonal gammopathies.
Wood PB; McElroy YG; Stone MJ
Clin Lymphoma Myeloma Leuk; 2010 Aug; 10(4):278-80. PubMed ID: 20709664
[TBL] [Abstract][Full Text] [Related]
8. The serum heavy/light chain immunoassay: A valuable tool for sensitive paraprotein assessment, risk, and disease monitoring in monoclonal gammopathies.
Greil C; Ihorst G; Gaiser F; Salzer U; Bisse E; Kastritis E; Ludwig H; Wäsch R; Engelhardt M
Eur J Haematol; 2017 Nov; 99(5):449-458. PubMed ID: 28886228
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
10. Detection of Plasma Cell Disorders by Mass Spectrometry: A Comprehensive Review of 19,523 Cases.
Dasari S; Kohlhagen MC; Dispenzieri A; Willrich MAV; Snyder MR; Kourelis TV; Lust JA; Mills JR; Kyle RA; Murray DL
Mayo Clin Proc; 2022 Feb; 97(2):294-307. PubMed ID: 34887112
[TBL] [Abstract][Full Text] [Related]
11. Strengths and weaknesses of methods for identifying monoclonal free light chains of Ig: examples from two cases with renal disease.
Levinson SS
Clin Chem Lab Med; 2016 Jun; 54(6):1039-43. PubMed ID: 26368046
[TBL] [Abstract][Full Text] [Related]
12. Serum free light chains in clinical laboratory diagnostics.
Jenner E
Clin Chim Acta; 2014 Jan; 427():15-20. PubMed ID: 23999048
[TBL] [Abstract][Full Text] [Related]
13. Specificity of serum and urine protein electrophoresis for the diagnosis of monoclonal gammopathies.
Katzmann JA; Stankowski-Drengler TJ; Kyle RA; Karen SL; Snyder MR; Lust JA; Dispenzieri A
Clin Chem; 2010 Dec; 56(12):1899-900. PubMed ID: 20844060
[No Abstract] [Full Text] [Related]
14. [Diagnostic accuracy of serum protein electrophoresis and free light chain measurements for monoclonal gammopathies].
Peña C; Ortiz M; Voisin J; Peralta A; Balboa V; Delgado F
Rev Med Chil; 2018 Jan; 146(1):64-67. PubMed ID: 29806679
[TBL] [Abstract][Full Text] [Related]
15. Use of serum free light chain analysis and urine protein electrophoresis for detection of monoclonal gammopathies.
Holding S; Spradbery D; Hoole R; Wilmot R; Shields ML; Levoguer AM; Doré PC
Clin Chem Lab Med; 2011 Jan; 49(1):83-8. PubMed ID: 20961192
[TBL] [Abstract][Full Text] [Related]
16. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
Böer K; Deufel T
Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis.
Napodano C; Pocino K; Gulli F; Colacicco L; Santini SA; Zuppi C; Basile U
J Clin Lab Anal; 2017 Mar; 31(2):. PubMed ID: 27424526
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic performance of serum free light chain measurement in patients suspected of a monoclonal B-cell disorder.
Vermeersch P; Van Hoovels L; Delforge M; Mariën G; Bossuyt X
Br J Haematol; 2008 Nov; 143(4):496-502. PubMed ID: 18729849
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin heavy/light chain ratios improve paraprotein detection and monitoring, identify residual disease and correlate with survival in multiple myeloma patients.
Ludwig H; Milosavljevic D; Zojer N; Faint JM; Bradwell AR; Hübl W; Harding SJ
Leukemia; 2013 Jan; 27(1):213-9. PubMed ID: 22955329
[TBL] [Abstract][Full Text] [Related]
20. Performance of the Sebia CAPILLARYS 2 for detection and immunotyping of serum monoclonal paraproteins.
Yang Z; Harrison K; Park YA; Chaffin CH; Thigpen B; Easley PL; Smith JA; Robinson CA; Lorenz RG; Hardy RW
Am J Clin Pathol; 2007 Aug; 128(2):293-9. PubMed ID: 17638665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
